Tensive Controls, Inc in Columbia is a biotech company focused on developing innovative peptide therapeutics. Their lead drug candidate, developed by Endevica Bio, targets cachexia associated with cancer and other chronic conditions.
With a mission to address unmet medical needs, Tensive Controls, Inc is dedicated to advancing treatments for debilitating diseases. Their cutting-edge research aims to improve the quality of life for patients suffering from cachexia.
Generated from their website's infomation